Trial · NCT06533982
Effect of Different Exercise Modalities on Cardiovascular and Cognitive Response in Postmenopausal Women
NCT06533982, Not applicable, Completed, University of Poitiers
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of Different Exercise Modalities on Cardiovascular and Cognitive Response in Postmenopausal Women. Trials, record NCT06533982. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06533982
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of Different Exercise Modalities on Cardiovascular and Cognitive Response in Postmenopausal Women
- NCT number
- NCT06533982
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 30 participants, actual
- Lead sponsor
- University of Poitiers
- Conditions
- Menopause, Blood Pressure, Cognitive Decline
- Interventions
- High intensity interval exercise session, Isometric neuromuscular exercise session
- First posted
- 2024-08-01
- Last updated
- 2024-08-01
Source ClinicalTrials.gov
Registered outcomes27
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Systolic and diastolic blood pressure (ambulatory blood pressure measurement) | After sessions (24 hours) | Post-exercise hypotension, using the Mobil-O-Graph (mmHg). |
| Primary | Systolic and diastolic blood pressure (resting) | Before and after sessions (15 minutes) | Automated oscillometric tensiometer (mmHg). |
| Secondary | Concentration of cerebral oxygenation | Before, during, and after sessions (1 hour) | Near-infrared spectroscopy is used to measure concentrations of oxygenated and desoxygenated hemoglobin (µmol/L). |
| Secondary | Working memory | Before and after sessions (10 minutes) | 2-back task (scored from 0 to 28, higher scores indicate better working memory). |
| Secondary | Episodic memory | Before and after sessions (15 minutes) | Memory scale III (MEM-III), a story recall task taken from the test battery in the Wechsler-Memory Scale-Revised (scored from 0 to 25, higher scores indicate better episodic memory). |
| Secondary | Executive function | Before and after sessions (15 minutes) | Stroop task, used to assess inhibitory control (scored as a ratio, negative score indicates worse inhibitory control vs. positive score indicates better inhibitory control). |
| Secondary | Perception of exertion | After sessions (1 minute) | Modified Borg scale (scored 0 to 10, higher score indicates lower exercise tolerance). |
| Secondary | Endothelial function (brachial artery dilation capacity) | Baseline (30 minutes) | At rest, the flow-mediated dilatation technique is used with high-resolution Doppler ultrasound (CX-50 Philipps). |
| Secondary | Baroreflex sensitivity | Baseline (1 hour) | At rest, baroreflex sensitivity is measured using the Finapres. |
| Secondary | Aortic systolic and diastolic blood pressure | Baseline (15 minutes) | At rest, using the SphygmoCor device, which measures central blood pressure (mmHg). |
1 to 10 of 27Source ClinicalTrials.gov
See all 27 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers9
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| 2-Back Task | Secondary outcome | ConductCognition |
| Short Story Recall | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06533982
GET https://conductscience.org/api/trials/v1/NCT06533982/registered?page=2